JPRN-UMIN000040178
Completed
未知
The antiemetic prophylaxis for the PONV (postoperative nausea and vomiting) in patients undergoing microvascular decompression: a prospective randomized controlled trial - PONV prevention in patients undergoing MVD
Department of Anesthesiology and Pain medicine, Seoul National University Bundang Hospital0 sites100 target enrollmentStarted: April 16, 2020Last updated:
ConditionsHealthy adults
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Department of Anesthesiology and Pain medicine, Seoul National University Bundang Hospital
- Enrollment
- 100
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 19years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Refuse to participate to the study Body Mass Index \< 18\.5 or \> 35 kg/m2 History of craniotomy History of chemotherapy History of preoperative antiemetics Severe renal or hepatic dysfunction Chronic opioid use Prolonged QTc (\>450ms)
Investigators
Similar Trials
Completed
Phase 4
A clinical trial comparing two drugs palonosetron and dexamethasone and their combination for prevention of post operative nausea and vomiting of patient undergoing laparoscopic cholecystectomy operatioHealth Condition 1: null- patient undergoing laparoscopic cholecystectomy operationCTRI/2013/05/003630Sanjay Gandhi Post Graduate Institute of Medical Sciences90
Recruiting
Phase 2
PROTREAT-TRIAL PROPHYLACTIC ANTIEMETIC TREATMENT OF OPIOID-INDUCED NAUSEA AND VOMITING (OINV) IN PALLIATIVE CARE: A RANDOMIZED CONTROLLED PHASE II FEASIBILITY TRIAOpioid induced Nausea and Vomiting (OINV)DRKS00024954niversitätsklinikum Freiburg Klinik für Palliativmedizin30
Active, not recruiting
Phase 1
One day antiemetic prophylaxis of NEPA (netupitant plus palonosetron) and dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients receiving a combination chemotherapy of doxorubicin or epirubicin with cyclophosphamide (AC-based regimen)Chemotherapy-Induced Nausea and Vomiting (CINV) in breast cancer patients receiving a combination chemotherapy of doxorubicin or epirubicin with cyclophosphamide (AC-based regimen)MedDRA version: 20.0Level: LLTClassification code 10008443Term: Chemotherapy antiemetic prophylaxsisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: PTClassification code 10054133Term: Prophylaxis of nausea and vomitingSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10008448Term: Chemotherapy induced emesis prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10049091Term: Chemotherapy antiemetic prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10008449Term: Chemotherapy inducted emesis prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10036899Term: Prophylaxis against chemotherapy induced vomitingSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2015-003316-20-ITCONSORZIO ONCOTECH150
Not yet recruiting
Not Applicable
Antiemetic prophylaxis from postoperative nausea and vomiting in orthognathic surgery: a randomized, double-blind comparison of granisetrojaw deformityJPRN-UMIN000046776Kyoto jaw deformity center, Rakuwakai Otowa Hospital244
Completed
Not Applicable
Antiementics and PONVSurgery PatientsJPRN-UMIN000024653Tokushima University200